Fiasp (Insulin Aspart) Will Be Another Mealtime Insulin Alternative
Reps will promote Fiasp (FEE-asp, insulin aspart) as an "ultrafast-acting" mealtime insulin for adults.
Think of Fiasp as similar to NovoLog. They're both insulin aspart from the same company...except Fiasp has an additive to speed absorption.
Fiasp starts working about 5 minutes faster than NovoLog.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote